生命科学资讯

Ventana Companion Diagnostics Market is Going to Boom | Agilent - openPR.com

Agilent Technologies (A) Valuation Check After FDA Expansion Of Keytruda Companion Diagnostic - simplywall.st

Agilent Technologies (A) Stock Analysis: Unpacking A 34.86% Potential Upside For Investors - DirectorsTalk Interviews

Agilent Technologies Stock: Quiet Rally, Hard Questions – Is The Lab Giant Still A Buy After Its C - AD HOC NEWS

The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st

Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat

Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat

The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - Sahm

BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN

Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance

Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat

FDA Ovarian Cancer Nod Puts Focus On Agilent Valuation And Momentum - simplywall.st

Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Agilent Receives FDA Approval for Companion Diagnostic in Ovarian Cancer - Femtech Insider

Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus

Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval

Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat

Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval - Fierce Biotech

Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net